4.7 Article

The case of fatal acute hemorrhagic necrotizing encephalitis in a two-month-old boy with Covid-19

Journal

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Volume 116, Issue -, Pages 151-153

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.ijid.2021.12.334

Keywords

SARS-CoV-2; COVID-19; child; neurological; encephalitis

Ask authors/readers for more resources

SARS-CoV-2 infection in healthy children is usually mild, but severe cases, especially in infants, have been reported. There is still limited data on the natural history of COVID-19 in pediatric population, highlighting the importance of describing rare manifestations in children's acute infection.
SARS-CoV-2 infection in healthy children is usually benign. However, severe, life-threatening cases have previously been reported, notably in infants. We must be aware that data on the natural history of COVID-19 are still full of gaps, especially as far as the pediatric population is concerned. Therefore, it is important to describe rare manifestations of SARS-CoV-2 acute infection in children. Here we present the case of acute hemorrhagic necrotizing encephalitis (AHNE) in a previously healthy, 2-month-old male infant with SARS-CoV-2 infection. After 2 days of fever with signs of respiratory tract infection, neurological manifestations appeared: irritability, nystagmus, agitation then apathy. As a consequence of apnea, he required emergent intubation and was transferred to our PICU. Brain MRI revealed diffuse areas of oedema associated with numerous symmetrical changes with punctate hemorrhages in basal ganglia, thalami, brainstem, and cerebral gray matter. CSF was clear with pleocytosis 484 cells/mu l, elevated lactic acid and protein. Despite broad microbiological testing, only SARS-CoV2 was detected in PCR nasal swab. Therefore, acute hemorrhagic necrotizing encephalitis (AHNE) as a result of COVID-19 was the most probable diagnosis. The outcome was unfavorable -brain death was confirmed, life support was withdrawn. (C) 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available